Drugmakers Must Face Warranty Claims In Valsartan MDL

By Bill Wichert · January 25, 2021, 4:06 PM EST

A New Jersey federal judge has said manufacturers, wholesalers and pharmacies cannot escape warranty claims in multidistrict litigation alleging they took part in distributing generic drugs containing the active ingredient valsartan...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION

Case Number

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

February 14, 2019

Recent Articles By Bill

September 10, 2024
Nelson Mullins Adds Baker Donelson Health Pro In Houston
December 13, 2023
NJ Litigator Rejoins Fox Rothschild After Healthcare GC Role
December 13, 2023
McDermott Brings Back Miami Litigator From County Atty Post
November 08, 2022
NJ Hospital Must Face Med Mal Suit As Other Hospital Exits
November 01, 2022
Rutgers Headed To Mediation Over COVID Whistleblower Suit
October 19, 2022
NJ Hospital CEO Fired Staffer For Ending Tryst, Suit Says
September 30, 2022
NJ Health System Loses Verdict To Recoup $15M Deal Fee
September 22, 2022
Rutgers Defeats Challenge To COVID-19 Vaccine Mandate
September 20, 2022
Cigna Slams NJ Lab's 'Contempt' In COVID-19 Coverage Suit
September 20, 2022
Princeton Wants To Ax Bias Suit Over COVID Policies